309 related articles for article (PubMed ID: 22035955)
21. Lipids and liver dysfunction in patients receiving parenteral nutrition.
Gabe SM
Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):150-5. PubMed ID: 23340009
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease.
Pastor-Clerigues A; Marti-Bonmati E; Milara J; Almudever P; Cortijo J
PLoS One; 2014; 9(12):e115404. PubMed ID: 25502575
[TBL] [Abstract][Full Text] [Related]
23. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
Cober MP; Teitelbaum DH
Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
[TBL] [Abstract][Full Text] [Related]
24. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.
Diamond IR; Sterescu A; Pencharz PB; Kim JH; Wales PW
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):209-15. PubMed ID: 19179884
[TBL] [Abstract][Full Text] [Related]
25. [Fish oil in prolonged parenteral nutrition in children--omega-3-fatty acids have a beneficial effect on the liver].
Strijbosch RA; van den Hoonaard TL; Olieman JF; Escher JC; Alwayn IP; Meijers-Ijsselstijn H
Ned Tijdschr Geneeskd; 2010; 154():A2003. PubMed ID: 20977797
[TBL] [Abstract][Full Text] [Related]
26. Intravenous lipids in home parenteral nutrition.
Pironi L; Agostini F; Guidetti M
World Rev Nutr Diet; 2015; 112():141-9. PubMed ID: 25471810
[TBL] [Abstract][Full Text] [Related]
27. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition.
Goulet O; Antébi H; Wolf C; Talbotec C; Alcindor LG; Corriol O; Lamor M; Colomb-Jung V
JPEN J Parenter Enteral Nutr; 2010; 34(5):485-95. PubMed ID: 20852176
[TBL] [Abstract][Full Text] [Related]
28. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
[TBL] [Abstract][Full Text] [Related]
29. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children.
Le HD; de Meijer VE; Robinson EM; Zurakowski D; Potemkin AK; Arsenault DA; Fallon EM; Malkan A; Bistrian BR; Gura KM; Puder M
Am J Clin Nutr; 2011 Sep; 94(3):749-58. PubMed ID: 21775562
[TBL] [Abstract][Full Text] [Related]
30. Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome.
Strang BJ; Reddix BA; Wolk RA
Nutr Clin Pract; 2016 Oct; 31(5):647-53. PubMed ID: 27143651
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Use of Mixed-Oil Lipid Emulsion in Adult Home Parenteral Nutrition Patients: A Case Series.
Mundi MS; McMahon MT; Carnell JJ; Hurt RT
Nutr Clin Pract; 2018 Dec; 33(6):851-857. PubMed ID: 29436744
[TBL] [Abstract][Full Text] [Related]
32. Total parenteral nutrition in patients with short bowel syndrome.
Ekema G; Milianti S; Boroni G
Minerva Pediatr; 2009 Jun; 61(3):283-91. PubMed ID: 19461572
[TBL] [Abstract][Full Text] [Related]
33. [Omega-3 fatty acids in parenteral nutrition: are they what makes the difference?].
Wanten G
Ned Tijdschr Geneeskd; 2010; 154():A2316. PubMed ID: 20977798
[TBL] [Abstract][Full Text] [Related]
34. Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction?
Nasr A; Diamond IR; de Silva NT; Wales PW
J Pediatr Surg; 2010 May; 45(5):980-6. PubMed ID: 20438939
[TBL] [Abstract][Full Text] [Related]
35. Rapid infusion of fish oil-based emulsion in infants does not appear to be associated with fat overload syndrome.
Gura KM; Puder M
Nutr Clin Pract; 2010 Aug; 25(4):399-402. PubMed ID: 20702846
[TBL] [Abstract][Full Text] [Related]
36. Omega-3-enriched lipid emulsion for liver salvage in parenteral nutrition-induced cholestasis in the adult patient.
Jurewitsch B; Gardiner G; Naccarato M; Jeejeebhoy KN
JPEN J Parenter Enteral Nutr; 2011 May; 35(3):386-90. PubMed ID: 21527601
[TBL] [Abstract][Full Text] [Related]
37. Fish oil lipid emulsions and immune response: what clinicians need to know.
Waitzberg DL; Torrinhas RS
Nutr Clin Pract; 2009; 24(4):487-99. PubMed ID: 19605803
[TBL] [Abstract][Full Text] [Related]
38. Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndrome.
Tillman EM; Crill CM; Black DD; Hak EB; Lazar LF; Christensen ML; Huang EY; Helms RA
Pharmacotherapy; 2011 May; 31(5):503-9. PubMed ID: 21923431
[TBL] [Abstract][Full Text] [Related]
39. Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.
Calkins KL; Havranek T; Kelley-Quon LI; Cerny L; Flores M; Grogan T; Shew SB
JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):404-411. PubMed ID: 26024828
[TBL] [Abstract][Full Text] [Related]
40. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.
Koletzko B; Goulet O
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):321-6. PubMed ID: 20393276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
